Abstract: The present disclosure relates to heat-treated Limosilactobacillus fermentum LM1020 for preventing hair loss and promoting hair growth, and more particularly, to heat-treated Limosilactobacillus fermentum LM1020 for preventing hair loss and promoting hair growth by promoting the proliferation of dermal papilla cells and a composition containing the same. Heat-treated Limosilactobacillus fermentum LM1020 of the present disclosure and a composition containing the same promotes the proliferation of dermal papilla cells, has excellent 5?-reductase-1 inhibitory activity, and promotes the expression of FGF7, FGF10, and EGF, which are growth factors, and thus have the effect of effect of preventing hair loss and promoting hair growth. The subject cell line referred to as Lactobacillus fermentum LM1020 has the International Depositary Authority accession number KCCM12918P, having been deposited on Dec. 23, 2020.

Abstract: A separator for an electrochemical device includes a porous polymer substrate; a first coating layer provided on at least one surface of the porous polymer substrate and containing a first polymer resin of a first solubility in an electrolyte; and a second coating layer provided on the first coating layer and including a second polymer resin of a second solubility in the electrolyte, and inorganic particles, wherein the first solubility is higher than the second solubility in the electrolyte, and the separator is provided on a negative electrode containing a silicon (Si).

Abstract: Provided is a method and an apparatus for dry-cleaning an aluminum nitride (AlN) heater for semiconductor fabrication equipment, which may efficiently remove fluorine-containing contaminants generated on the AlN heater during semiconductor fabrication processes, and especially, may effectively and simultaneously remove organic, inorganic metallic, and inorganic contaminants. The method for dry-cleaning an AlN heater for semiconductor fabrication equipment includes steps of: determining a laser to be used for the AlN heater; determining laser control factors required for cleaning the AlN heater with respect to the laser to be used determined in the step of determining the laser to be used; and cleaning the AlN heater by laser irradiation based on the laser control factors determined in the step of determining the laser control factors.

Abstract: Disclosed is a stable liquid formulation, comprising an antibody or antigen-binding portion thereof, an acetate buffer, glycine, and a surfactant, wherein the stable liquid formulation does not comprise at least one of sugar, a sugar alcohol and a metal salt, and the stable liquid formulation is still stable even upon high antibody content, and is superior in osmolality and viscosity, and subcutaneous administration thereof is possible.

Abstract: Disclosed are a sulfide-based solid electrolyte including boron and having a face-centered cubic crystalline phase and a method of manufacturing the same.

Abstract: A smaller and lighter diffraction light guide plate, and a method of manufacturing the same.

Abstract: The present disclosure provides an apparatus for manufacturing a diffractive optical element, the apparatus including: a prism for manufacturing a diffractive optical element, the prism comprising a photoreactive material attachment surface and a light reflecting surface inclined at a predetermined angle from the photoreactive material attachment surface; and a light source positioned at the opposite side of the prism with respect to the photoreactive material attached to the photoreactive material attachment surface, and configured to irradiate light toward the photoreactive material, and a method for manufacturing a diffractive optical element.

Abstract: A stable liquid pharmaceutical preparation of an anti-influenza virus antibody and, more specifically, a stable liquid pharmaceutical preparation that comprises: (A) an anti-influenza virus antibody or a mixture of two or more different types of anti-influenza virus antibodies; (B) a surfactant; (C) a sugar or a sugar derivative; and (D) an amino acid. The stable liquid pharmaceutical preparation for an anti-influenza virus antibody disclosed herein has excellent storage stability at low temperature (5° C.), room temperature (25° C.), and high temperature (40° C.) and excellent long-term (12 months) storage stability, and may be administered intravenously, intramuscularly, transdermally, subcutaneously, intraperitoneally, topically, or in combinations thereof.

Abstract: The present invention provides a stable liquid pharmaceutical formulation containing: an antibody or its antigen-binding fragment; a surfactant; a sugar or its derivative; and a buffer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity while containing a high content of the antibody, has excellent long-term storage stability based on excellent stability under accelerated conditions and severe conditions, and may be administered subcutaneously.

Abstract: The present invention provides a stable liquid pharmaceutical formulation containing: an antibody or its antigen-binding fragment; a surfactant; a sugar or its derivative; and a buffer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity while containing a high content of the antibody, has excellent long-term storage stability based on excellent stability under accelerated conditions and severe conditions, and may be administered subcutaneously.

Abstract: The present disclosure relates to a plurality of host materials comprising at least one first host compound and at least one second host compound and an organic electroluminescent device comprising the same. By comprising the specific combination of the compound according to the present disclosure as host materials, an organic electroluminescent device having low driving voltage, high luminous efficiency, and long lifespan characteristics can be prepared.

Abstract: In a user interface method, system and device in a multitasking environment, it is possible for a user to view all of a plurality of simultaneously executed applications by assigning different display areas to the plurality of applications. In the method, system and device, priorities of applications already being executed and of additional applications for which execution is requested are determined, and a display area size is determined and assigned to each application according to its priority. The system comprises a set-top box for performing the latter functions and a user terminal for transmitting a user request, while the device comprises a control unit for performing the latter functions.

Abstract: Provided is a cosmetic composition for skin improvement including a green barley extract.

Abstract: In a user interface method, system and device in a multitasking environment, it is possible for a user to view all of a plurality of simultaneously executed applications by assigning different display areas to the plurality of applications. In the method, system and device, priorities of applications already being executed and of additional applications for which execution is requested are determined, and a display area size is determined and assigned to each application according to its priority. The system comprises a set-top box for performing the latter functions and a user terminal for transmitting a user request, while the device comprises a control unit for performing the latter functions.

Abstract: In a user interface method, system and device in a multitasking environment, it is possible for a user to view all of a plurality of simultaneously executed applications by assigning different display areas to the plurality of applications. In the method, system and device, priorities of applications already being executed and of additional applications for which execution is requested are determined, and a display area size is determined and assigned to each application according to its priority. The system comprises a set-top box for performing the latter functions and a user terminal for transmitting a user request, while the device comprises a control unit for performing the latter functions.

Abstract: Methods and systems for audio content production are provided whereby expressive speech is generated via acoustic elements extracted from human input. One of the inputs to the system is a human designating an intonation to be applied onto text-to-speech (TTS) generated synthetic speech. The human intonation includes the pitch contour and other acoustic features extracted from the speech. The system is designed to be used for, and is capable of speech generation, speech analysis, speech transformation, and speech re-synthesis at the acoustic level.